These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 30304392)

  • 1. A novel murine model for arrhythmogenic cardiomyopathy points to a pathogenic role of Wnt signalling and miRNA dysregulation.
    Calore M; Lorenzon A; Vitiello L; Poloni G; Khan MAF; Beffagna G; Dazzo E; Sacchetto C; Polishchuk R; Sabatelli P; Doliana R; Carnevale D; Lembo G; Bonaldo P; De Windt L; Braghetta P; Rampazzo A
    Cardiovasc Res; 2019 Mar; 115(4):739-751. PubMed ID: 30304392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of cardiac Wnt/β-catenin signalling in desmoplakin-deficient AC8 zebrafish models is rescuable by genetic and pharmacological intervention.
    Giuliodori A; Beffagna G; Marchetto G; Fornetto C; Vanzi F; Toppo S; Facchinello N; Santimaria M; Vettori A; Rizzo S; Della Barbera M; Pilichou K; Argenton F; Thiene G; Tiso N; Basso C
    Cardiovasc Res; 2018 Jul; 114(8):1082-1097. PubMed ID: 29522173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal Models and Molecular Pathogenesis of Arrhythmogenic Cardiomyopathy Associated with Pathogenic Variants in Intercalated Disc Genes.
    Vencato S; Romanato C; Rampazzo A; Calore M
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy.
    Pilichou K; Nava A; Basso C; Beffagna G; Bauce B; Lorenzon A; Frigo G; Vettori A; Valente M; Towbin J; Thiene G; Danieli GA; Rampazzo A
    Circulation; 2006 Mar; 113(9):1171-9. PubMed ID: 16505173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intercalated disc abnormalities, reduced Na(+) current density, and conduction slowing in desmoglein-2 mutant mice prior to cardiomyopathic changes.
    Rizzo S; Lodder EM; Verkerk AO; Wolswinkel R; Beekman L; Pilichou K; Basso C; Remme CA; Thiene G; Bezzina CR
    Cardiovasc Res; 2012 Sep; 95(4):409-18. PubMed ID: 22764152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desmoglein 2-Dependent Arrhythmogenic Cardiomyopathy Is Caused by a Loss of Adhesive Function.
    Kant S; Holthöfer B; Magin TM; Krusche CA; Leube RE
    Circ Cardiovasc Genet; 2015 Aug; 8(4):553-63. PubMed ID: 26085008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic fate mapping identifies second heart field progenitor cells as a source of adipocytes in arrhythmogenic right ventricular cardiomyopathy.
    Lombardi R; Dong J; Rodriguez G; Bell A; Leung TK; Schwartz RJ; Willerson JT; Brugada R; Marian AJ
    Circ Res; 2009 May; 104(9):1076-84. PubMed ID: 19359597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A microRNA Expression Profile as Non-Invasive Biomarker in a Large Arrhythmogenic Cardiomyopathy Cohort.
    Bueno Marinas M; Celeghin R; Cason M; Bariani R; Frigo AC; Jager J; Syrris P; Elliott PM; Bauce B; Thiene G; Corrado D; Basso C; Pilichou K
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hippo pathway is activated and is a causal mechanism for adipogenesis in arrhythmogenic cardiomyopathy.
    Chen SN; Gurha P; Lombardi R; Ruggiero A; Willerson JT; Marian AJ
    Circ Res; 2014 Jan; 114(3):454-68. PubMed ID: 24276085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High risk of heart failure associated with desmoglein-2 mutations compared to plakophilin-2 mutations in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Hermida A; Fressart V; Hidden-Lucet F; Donal E; Probst V; Deharo JC; Chevalier P; Klug D; Mansencal N; Delacretaz E; Cosnay P; Scanu P; Extramiana F; Keller DI; Rouanet S; Charron P; Gandjbakhch E
    Eur J Heart Fail; 2019 Jun; 21(6):792-800. PubMed ID: 30790397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmoglein 2 mutation provokes skeletal muscle actin expression and accumulation at intercalated discs in murine hearts.
    Kant S; Freytag B; Herzog A; Reich A; Merkel R; Hoffmann B; Krusche CA; Leube RE
    J Cell Sci; 2019 Feb; 132(5):. PubMed ID: 30659114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing the Molecular Pathology of Arrhythmogenic Cardiomyopathy in Patient Buccal Mucosa Cells.
    Asimaki A; Protonotarios A; James CA; Chelko SP; Tichnell C; Murray B; Tsatsopoulou A; Anastasakis A; te Riele A; Kléber AG; Judge DP; Calkins H; Saffitz JE
    Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003688. PubMed ID: 26850880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling of differentially expressed microRNAs in arrhythmogenic right ventricular cardiomyopathy.
    Zhang H; Liu S; Dong T; Yang J; Xie Y; Wu Y; Kang K; Hu S; Gou D; Wei Y
    Sci Rep; 2016 Jun; 6():28101. PubMed ID: 27307080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of Patients With Arrhythmogenic Left Ventricular Cardiomyopathy: Combining Genetic and Histopathologic Findings.
    Casella M; Gasperetti A; Sicuso R; Conte E; Catto V; Sommariva E; Bergonti M; Vettor G; Rizzo S; Pompilio G; Andreini D; Saguner AM; Duru F; Natale A; Thiene G; Basso C; Dello Russo A; Tondo C
    Circ Arrhythm Electrophysiol; 2020 Dec; 13(12):e009005. PubMed ID: 33197325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel pathogenic role for galectin-3 in early disease stages of arrhythmogenic cardiomyopathy.
    Cason M; Celeghin R; Marinas MB; Beffagna G; Della Barbera M; Rizzo S; Remme CA; Bezzina CR; Tiso N; Bauce B; Thiene G; Basso C; Pilichou K
    Heart Rhythm; 2021 Aug; 18(8):1394-1403. PubMed ID: 33857645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large Genomic Rearrangements of Desmosomal Genes in Italian Arrhythmogenic Cardiomyopathy Patients.
    Pilichou K; Lazzarini E; Rigato I; Celeghin R; De Bortoli M; Perazzolo Marra M; Cason M; Jongbloed J; Calore M; Rizzo S; Regazzo D; Poloni G; Iliceto S; Daliento L; Delise P; Corrado D; Van Tintelen JP; Thiene G; Rampazzo A; Basso C; Bauce B; Lorenzon A; Occhi G
    Circ Arrhythm Electrophysiol; 2017 Oct; 10(10):. PubMed ID: 29038103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Yang Z; Bowles NE; Scherer SE; Taylor MD; Kearney DL; Ge S; Nadvoretskiy VV; DeFreitas G; Carabello B; Brandon LI; Godsel LM; Green KJ; Saffitz JE; Li H; Danieli GA; Calkins H; Marcus F; Towbin JA
    Circ Res; 2006 Sep; 99(6):646-55. PubMed ID: 16917092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro analysis of arrhythmogenic cardiomyopathy associated desmoglein-2 (DSG2) mutations reveals diverse glycosylation patterns.
    Debus JD; Milting H; Brodehl A; Kassner A; Anselmetti D; Gummert J; Gaertner-Rommel A
    J Mol Cell Cardiol; 2019 Apr; 129():303-313. PubMed ID: 30885746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sudden death during exercise in a juvenile with arrhythmogenic right ventricular cardiomyopathy and desmoglein-2 gene substitution: a case report.
    Sato T; Nishio H; Suzuki K
    Leg Med (Tokyo); 2011 Nov; 13(6):298-300. PubMed ID: 22000064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of PPARα Ameliorates Cardiac Fibrosis in Dsg2-Deficient Arrhythmogenic Cardiomyopathy.
    Qiu Z; Zhao Y; Tao T; Guo W; Liu R; Huang J; Xu G
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.